论文部分内容阅读
体外反搏器是一种新型的心脏病治疗和抢救装置。它可用于急性心肌梗塞、各类心绞痛,隐性冠心病,脑动脉硬化等疾病的治疗,亦可对病人进行心电、心率、脉搏等监护。1975年以来,继中山医学院等10个单位组成的“广州市反搏系统研制协作组,研制成功我国第一台“主动脉内气囊反搏器”与四肢序贯式正压体外反搏装置之后,广州医疗器械厂与广州电子仪器厂于1979年又分别试制了 WFB-1型和 WFB-2A 型体外反搏器,并经中山医学院附属一院,北京友谊医院等单位临床试用,证实性能稳定,效果良好。
Extracorporeal pacemakers are a new type of heart treatment and rescue device. It can be used for the treatment of acute myocardial infarction, various types of angina pectoris, recessive coronary heart disease, cerebral arteriosclerosis and other diseases. The patients can also be monitored by ECG, heart rate and pulse. Since 1975, following the Zhongshan Medical College and other 10 units of the “Guangzhou City counterpulsation system development collaboration group, the successful development of China’s first” intra-aortic balloon pump "and extremities sequential positive pressure EECP device After that, Guangzhou Medical Instrument Factory and Guangzhou Electronic Instrument Factory tried out the WFB-1 and WFB-2A external pacemaker respectively in 1979 and passed the trial of clinical trial of Affiliated Hospital of Zhongshan Medical College and Beijing Friendship Hospital Stable performance, good effect.